Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MDXH MDxHealth SA Ordinary Shares
$0.74 3.19% +0.02
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MDXH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 70.9M
Enterprise value 125.6M
Trailing PE -1.1076119408679
Forward PE -1.9555264
PEG Ratio 0.10522313438245
Enterprise to EBITDA -8.413
Enterprise to revenue 1.101
Price to book MRQ -1.9134442290917
Price to sales TTM 0.62183976

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 114.0M
EBITDA -14928000
Diluted EPS TTM -0.72
Total Cash (MRQ) 19.2M
Current ratio (MRQ) 1.15
Operating Cash Flow (TTM) -5300000

MDXH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MDXH News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.